Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Multicenter, Double-Blind, Placebo Controlled, Efficacy, Safety, and Pharmacokinetic Study of 2 Doses of CXA-10 on Stable Background Therapy in Subjects With Pulmonary Arterial Hypertension

NCT03449524 is registered in ClinicalTrials.gov with Complexa, Inc. as lead sponsor.

NCT NCT03449524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03449524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Multicenter, Double-Blind, Placebo Controlled, Efficacy, Safety, and Pharmacokinetic Study of 2 Doses of CXA-10 on Stable Background Therapy in Subjects With Pulmonary Arterial Hypertension
Lead sponsor
Complexa, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
August 1, 2018
Completion date
August 5, 2020
Enrollment
69 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

pah